Viewing Study NCT01776606


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2025-12-26 @ 2:40 PM
Study NCT ID: NCT01776606
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2013-01-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Sponsor: Revance Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module